Early detection of community acquired of SARS-CoV-2 lineage B.1.351 in Hong Kong [0.03%]
香港早期检测到社区B.1.351谱系新冠病毒感染者
Alan K L Tsang,Gannon C K Mak,Peter K C Cheng et al.
Alan K L Tsang et al.
Background: Prior to this report, variants of concern for SARS-CoV-2 were only detected from imported cases in Hong Kong. Objective: Mu...
Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland [0.03%]
用于苏格兰流行病学监测的SARS-CoV-2血清学检测试剂盒比较
Lindsay McDonald,Helen Wise,Frauke Muecksch et al.
Lindsay McDonald et al.
Background: Sero-surveillance of SARS-CoV-2 is crucial to monitoring levels of population exposure and informing public health responses, but may be influenced by variability in performance between available assays. ...
Characteristics of children with confirmed SARS-CoV-2 infection in Indonesia [0.03%]
印度尼西亚确诊SARS-CoV-2感染儿童的特征分析
Amin Soebandrio,Tina Kusumaningrum,Frilasita A Yudhaputri et al.
Amin Soebandrio et al.
Objective: COVID-19 in children poses a significant challenge due to the atypical/asymptomatic presentations. The study is aimed to help understand clinical characteristics in Indonesian children for better management and...
Pediatric SARS-CoV-2 seroprevalence during mitigation procedures in Southwestern Pennsylvania [0.03%]
在美国西南部宾夕法尼亚州疫情期间儿童新冠病毒血清阳性率
Glenn J Rapsinski,Megan Culler Freeman,Ghady Haidar et al.
Glenn J Rapsinski et al.
Background: Children infected with SARS-CoV-2 are often asymptomatic or have only mild symptoms, leading to underestimation of disease prevalence in symptom-based testing strategies. ...
Use of amplicon melt temperature to detect SARS-CoV-2 Lineage B.1.1.7 variant through the G28048T mutation in the ORF 8 gene [0.03%]
利用SARS-CoV-2基因型B.1.1.7的ORF8基因G28048T变异的扩增子熔解温度检测该病毒变体
Richard S Hale,Ashleigh Green,Emma Cunningham et al.
Richard S Hale et al.
A new variant of SARS-CoV-2 (Lineage B.1.1.7) was identified in the UK in December 2020 which was associated with higher transmissibility of COVID-19. The AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay is used at sixteen UK hospi...
Post-COVID-19 vaccination absolute risk to front line health care workers [0.03%]
新冠疫苗接种后一线医疗保健工作人员的绝对风险
Steven Sorscher
Steven Sorscher
Evaluation of the performance of the quotient MosaiQ™ COVID-19 professional use microarray assay for the detection of antibodies to SARS CoV-2 in a clinical setting [0.03%]
评估商量化商MosaiQ™COVID-19专业用途微阵列测定法在临床环境中检测SARS-CoV-2抗体的性能
José Vicario,Raquel Alenda-Asensi,Irene Lucea-Gallego et al.
José Vicario et al.
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests [0.03%]
新冠病毒核酸检测单一靶标阳性的解读分析
Honorine Fenaux,Théo Ghelfenstein-Ferreira,Maud Salmona et al.
Honorine Fenaux et al.
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged and is responsible for coronavirus disease 19 (COVID-19). Diagnostic tests have been developed, mainly based on reverse-transcripta...
Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT- PCR for the detection of SARS-CoV-2: A contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness [0.03%]
评估罗氏抗原快速检测试剂盒和基于细胞培养的检测方法与rRT-PCR检测SARS-CoV-2的性能：关于SARS-CoV-2诊断试剂及传染性的讨论
Jacqueline Steinlin-Schopfer,Maria Teresa Barbani,Richard Kamgang et al.
Jacqueline Steinlin-Schopfer et al.
Background: The most sensitive method to detect SARS-CoV-2 relies on rRT-PCR; however, viral RNA can be detected weeks/months after clinical resolution. Since rRT-PCR cannot discern between non- and infectious virus, it i...
Antigenic rapid test for SARS-CoV2 screening of individuals newly admitted to detention facilities: sensibility in an asymptomatic cohort [0.03%]
用于新收容人员SARS-CoV-2筛查的抗原快速检测：无症状队列中的灵敏度评估
Sara Mazzilli,Francesco Oliani,Andrea Restivo et al.
Sara Mazzilli et al.
Background: Since the start of the Sars-CoV-2 pandemic, attention was called on the potential risk of COVID-19 outbreaks occurring inside prisons. In detention facilities, timely and accurate diagnosis is essential for al...